Peptavo is Accredited for 20 CME hours.Peptavo is Jointly Accredited for 20 CME hours. Learn more about accreditation
PEPTAVO
The Stack Source LLC1908 E 11th Street Austin, TX 78702support@peptavo.com(512) 827-8158DBA: Peptavo
Peptavo is Accredited for 20 CME hours.Peptavo is Jointly Accredited for 20 CME hours. Learn more about accreditation
Get volume discounts if you are getting 3 or more clinicians certified
Book a Call
The Peptavo Clinical Library answers the questions clinicians face before training, prescribing, and building a peptide service. Every clinical guide uses primary sources and identifies its medical reviewer.
Legal & Compliance
Peptides are legal in California when federal law allows the product and the clinician follows California's rules on examinations, scope of practice, pharmacy licensing, and clinic ownership. Here is what the Medical Board, the Board of Pharmacy, and the 2026 legislature add to federal law.
Legal & Compliance
Many peptides are legal in the US. Whether a specific one is depends on how it reaches the patient: as an FDA-approved drug, a compounded prescription, a supplement, or a vial sold for research use only. Here is how each pathway works, what changed in 2026, and what Florida, California, and Texas add.
Certification & CME
Nine peptide therapy certification courses for clinicians, compared on price, CME credit, format, length, faculty, and membership, using what each provider lists on its own page in October 2026.
Certification & CME
A credential earns trust when anyone can confirm it. How the Peptavo registry lets patients, employers, and referring clinicians check a certificate number in seconds.
Certification & CME
Enrollment is open to anyone, and the certification is earned by passing ten graded modules at 75 percent. Here is who it is built for and how each profession claims CE credit.
Certification & CME
The credential attests to ten modules passed under assessment, up to twenty accredited CE credits, seventeen hours of advanced curriculum, and a public registry entry any patient can check.
Legal & Compliance
The July 2026 PCAC votes moved six peptide families one step forward, but they did not approve drugs, amend the 503A Bulks List, or change what clinicians may source today.
Practice Operations
How to open the conversation without endorsing hype or shutting down curiosity.